Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial

Last updated: May 23, 2024
Sponsor: University Hospital Tuebingen
Overall Status: Completed

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

Standard Care

Ice Plant Intensive Cream plus Standard Care

Clinical Study ID

NCT05755646
S00748-NIM
  • Ages > 18
  • Female

Study Summary

The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Breast cancer patients

  • Therapy with Doxorubicin and/or Docetaxel

  • Karnofsky performance status scale > 80

  • Informed consent

Exclusion

Exclusion Criteria:

  • Patients with previous skin disease and/or polyneuropathy

  • Intolerance or allergic reaction on at least one ingredient of Ice Plant IntensiveCream

  • Already receiving chemotherapy

  • Usage of Ice Plant Intensive Cream before trial

  • Severe physical or psychological illness due to which the patient is not able toparticipate in the study

  • Lack of German language skills

Study Design

Total Participants: 36
Treatment Group(s): 2
Primary Treatment: Standard Care
Phase:
Study Start date:
March 10, 2023
Estimated Completion Date:
May 02, 2024

Connect with a study center

  • Robert-Bosch-Hospital

    Stuttgart,
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.